Medicare Enrolled

Dr. Mark Melden, D.O.

Child & Adolescent Psychiatry Physician · Coronado, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
158 C AVE, Coronado, CA 92118
6194355400
In practice since 2006 (19 years)
NPI: 1982653135 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melden from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melden? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Melden

Dr. Mark Melden is a child & adolescent psychiatry physician in Coronado, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Melden performed 2,995 Medicare services across 566 unique beneficiaries.

Between the years covered by Open Payments, Dr. Melden received a total of $9,128 from 38 pharmaceutical and/or device companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Melden is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 2% volume in CA $9,128 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,995
Medicare services
Top 2% in CA for child & adolescent psychiatry physician
566
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~158 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
 1,402 $52 $250
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 1,251 $68 $250
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 182 $101 $250
Psychiatric services complicated by communication factor
Psychiatric evaluation or treatment provided when communication barriers complicate the interaction between the provider and the patient.
 111 $11 $100
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
 49 $142 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,128
Total received (2018-2024)
Avg $1,304/year across 7 years
Top 5% in CA for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
431
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,993 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$134 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,259
2023
$997
2022
$816
2021
$1,145
2020
$1,003
2019
$2,003
2018
$1,905

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$242
ABBVIE INC.
$170
Otsuka America Pharmaceutical, Inc.
$165
Lundbeck LLC
$122
Corium, LLC
$90
Neurocrine Biosciences, Inc.
$84
Vanda Pharmaceuticals Inc.
$78
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$77
Indivior Inc.
$67
E.R. Squibb & Sons, L.L.C.
$60
Supernus Pharmaceuticals, Inc.
$57
Janssen Pharmaceuticals, Inc
$25
Bausch Health US, LLC
$23
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$815
Janssen Pharmaceuticals, Inc
$780
Takeda Pharmaceuticals U.S.A., Inc.
$736
Otsuka America Pharmaceutical, Inc.
$706
Alkermes, Inc.
$657
Lundbeck LLC
$622
Vanda Pharmaceuticals Inc.
$496
AbbVie Inc.
$474
Allergan, Inc.
$396
ABBVIE INC.
$384
Allergan Inc.
$373
ITI, Inc.
$302
Sunovion Pharmaceuticals Inc.
$293
Neurocrine Biosciences, Inc.
$258
Corium, LLC
$217
Indivior Inc.
$212
Shire North American Group Inc
$208
Neos Therapeutics, LP
$164
Supernus Pharmaceuticals, Inc.
$154
Bausch Health US, LLC
$139
Ironshore Pharmaceuticals Inc.
$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$77
ARBOR PHARMACEUTICALS, INC.
$69
Axsome Therapeutics, Inc.
$63
E.R. Squibb & Sons, L.L.C.
$60
Neuronetics, Inc.
$58
Avanir Pharmaceuticals, Inc.
$50
Merck Sharp & Dohme LLC
$39
Jazz Pharmaceuticals Inc.
$33
Merck Sharp & Dohme Corporation
$30
Almatica Pharma LLC
$30
Boston Scientific Corporation
$28
Corium, Inc.
$23
Alfasigma USA, Inc.
$22
Tris Pharma Inc
$22
JAZZ PHARMACEUTICALS INC.
$21
Aytu BioScience, Inc
$20
Vertical Pharmaceuticals, LLC
$18
Top 3 companies account for 25.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · CITALOPRAM · COBENFY · Evekeo · FANAPT · Fanapt · GENERAL PAIN MANAGEMENT · HETLIOZ · Hetlioz · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · Natesto · Nuedexta · PERSERIS · QELBREE · Qelbree · Quillivant XR · RELEXXII · REXULTI · SPRAVATO · SUBLOCADE · SUNOSI · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Vivitrol 380 mg · Vyvanse · WELLBUTRIN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for child & adolescent psychiatry physician in CA.

Looking for a child & adolescent psychiatry physician in Coronado?
Compare child & adolescent psychiatry physicians in the Coronado area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & adolescent psychiatry physicians within 10 mi
82
Per 100K population
2.5
County median income
$102,285
Nearest hospital
SHARP CORONADO HOSPITAL AND HLTHCR CTR
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Melden is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Melden experienced with psychotherapy and evaluation, 30 minutes?
Based on Medicare claims data, Dr. Melden performed 1,402 psychotherapy and evaluation, 30 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melden receive payments from pharmaceutical companies?
Yes. Dr. Melden received a total of $9,128 from 38 companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melden's costs compare to other child & adolescent psychiatry physicians in Coronado?
Dr. Melden's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melden) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Child & Adolescent Psychiatry Physicians in Coronado
Browse child & adolescent psychiatry physicians in Coronado ranked by procedure volume and transparency data.
Highest volume
Top Child & Adolescent Psychiatry Physicians in CA
Child & adolescent psychiatry physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Child & Adolescent Psychiatry Physicians in CA
Which CA child & adolescent psychiatry physicians receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →